Wang Donghua, Yuan Rongwen, Feng Ye, El-Asady Riham, Farber Donna L, Gress Ronald E, Lucas Philip J, Hadley Gregg A
Department of Surgery, University of Maryland Medical School, 10 South Pine Street, Baltimore, MD 21201, USA.
J Immunol. 2004 Jan 1;172(1):214-21. doi: 10.4049/jimmunol.172.1.214.
CD103 is an integrin with specificity for the epithelial cell-specific ligand, E-cadherin. Recent studies indicate that CD103 expression endows peripheral CD8 cells with a unique capacity to access the epithelial compartments of organ allografts. In the present study we used a nonvascularized mouse renal allograft model to 1) define the mechanisms regulating CD103 expression by graft-infiltrating CD8 effector populations, and 2) identify the cellular compartments in which this occurs. We report that CD8 cells responding to donor alloantigens in host lymphoid compartments do not initially express CD103, but dramatically up-regulate CD103 expression to high levels subsequent to migration to the graft site. CD103+CD8+ cells that infiltrated renal allografts exhibited a classic effector phenotype and were selectively localized to the graft site. CD8 cells expressing low levels of CD103 were also present in lymphoid compartments, but three-color analyses revealed that these are almost exclusively of naive phenotype. Adoptive transfer studies using TCR-transgenic CD8 cells demonstrated that donor-specific CD8 cells rapidly and uniformly up-regulate CD103 expression following entry into the graft site. Donor-specific CD8 cells expressing a dominant negative TGF-beta receptor were highly deficient in CD103 expression following migration to the graft, thereby implicating TGF-beta activity as a dominant controlling factor. The relevance of these data to conventional (vascularized) renal transplantation is confirmed. These data support a model in which TGF-beta activity present locally at the graft site plays a critical role in regulating CD103 expression, and hence the epitheliotropism, of CD8 effector populations that infiltrate renal allografts.
CD103是一种整合素,对上皮细胞特异性配体E-钙黏蛋白具有特异性。最近的研究表明,CD103的表达赋予外周CD8细胞进入器官同种异体移植物上皮区室的独特能力。在本研究中,我们使用非血管化小鼠肾同种异体移植模型来:1)确定调节移植物浸润性CD8效应细胞群体表达CD103的机制,以及2)确定发生这种情况的细胞区室。我们报告称,在宿主淋巴区室中对供体同种异体抗原作出反应的CD8细胞最初不表达CD103,但在迁移到移植部位后会显著上调CD103的表达至高水平。浸润肾同种异体移植物的CD103+CD8+细胞表现出典型的效应细胞表型,并选择性地定位于移植部位。表达低水平CD103的CD8细胞也存在于淋巴区室中,但三色分析显示这些细胞几乎完全是幼稚表型。使用TCR转基因CD8细胞进行的过继转移研究表明,供体特异性CD8细胞进入移植部位后会迅速且一致地上调CD103的表达。表达显性负性TGF-β受体的供体特异性CD8细胞迁移到移植部位后,CD103的表达高度缺陷,从而表明TGF-β活性是一个主要的控制因素。这些数据与传统(血管化)肾移植的相关性得到了证实。这些数据支持了一种模型,即移植部位局部存在的TGF-β活性在调节浸润肾同种异体移植物的CD8效应细胞群体的CD103表达以及上皮嗜性方面起着关键作用。